WO2002083070A3 - Compounds for immunotherapy and diagnosis of colon cancer and methods for their use - Google Patents

Compounds for immunotherapy and diagnosis of colon cancer and methods for their use Download PDF

Info

Publication number
WO2002083070A3
WO2002083070A3 PCT/US2002/011475 US0211475W WO02083070A3 WO 2002083070 A3 WO2002083070 A3 WO 2002083070A3 US 0211475 W US0211475 W US 0211475W WO 02083070 A3 WO02083070 A3 WO 02083070A3
Authority
WO
WIPO (PCT)
Prior art keywords
diagnosis
protein
colon cancer
methods
compositions
Prior art date
Application number
PCT/US2002/011475
Other languages
French (fr)
Other versions
WO2002083070A2 (en
Inventor
Jiangchun Xu
Michael J Lodes
Heather Secrist
Darin R Benson
Madeleine Joy Meagher
John A Stolk
Tongtong Wang
Yuqiu Jiang
Carole L Smith
Gordon E King
Aijun Wang
Jonathan D Clapper
Yasir A W Skeiky
Gary R Fanger
Thomas S Vedvick
Darrick Carter
Original Assignee
Corixa Corp
Jiangchun Xu
Michael J Lodes
Heather Secrist
Darin R Benson
Madeleine Joy Meagher
John A Stolk
Tongtong Wang
Yuqiu Jiang
Carole L Smith
Gordon E King
Aijun Wang
Jonathan D Clapper
Yasir A W Skeiky
Gary R Fanger
Thomas S Vedvick
Darrick Carter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/833,263 external-priority patent/US20020110547A1/en
Priority claimed from US09/922,217 external-priority patent/US20020076414A1/en
Priority claimed from US10/025,380 external-priority patent/US20020182191A1/en
Application filed by Corixa Corp, Jiangchun Xu, Michael J Lodes, Heather Secrist, Darin R Benson, Madeleine Joy Meagher, John A Stolk, Tongtong Wang, Yuqiu Jiang, Carole L Smith, Gordon E King, Aijun Wang, Jonathan D Clapper, Yasir A W Skeiky, Gary R Fanger, Thomas S Vedvick, Darrick Carter filed Critical Corixa Corp
Priority to AU2002256186A priority Critical patent/AU2002256186A1/en
Publication of WO2002083070A2 publication Critical patent/WO2002083070A2/en
Publication of WO2002083070A3 publication Critical patent/WO2002083070A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Compositions and methods for the therapy and diagnosis of cancer, such as colon cancer, are disclosed. Compositions may comprise one or more colon tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapic composition may comprise an antigen presenting cell that expresses a colon tumor protein, or a T cell that is specific for cells expressing such a protein. Such compositions may be used, for example, for the prevention and treatment of diseases such as colon cancer. Diagnostic methods based on detecting a colon tumor protein, or mRNA encoding such a protein, in a sample are also provided.
PCT/US2002/011475 2001-04-10 2002-04-09 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use WO2002083070A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002256186A AU2002256186A1 (en) 2001-04-10 2002-04-09 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US09/833,263 2001-04-10
US09/833,263 US20020110547A1 (en) 1998-12-23 2001-04-10 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
US09/922,217 US20020076414A1 (en) 1998-12-23 2001-08-03 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
US09/922,217 2001-08-03
US10/025,380 US20020182191A1 (en) 1998-12-23 2001-12-19 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
US10/025,380 2001-12-19

Publications (2)

Publication Number Publication Date
WO2002083070A2 WO2002083070A2 (en) 2002-10-24
WO2002083070A3 true WO2002083070A3 (en) 2004-11-11

Family

ID=27362526

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/011475 WO2002083070A2 (en) 2001-04-10 2002-04-09 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use

Country Status (1)

Country Link
WO (1) WO2002083070A2 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6893818B1 (en) 1999-10-28 2005-05-17 Agensys, Inc. Gene upregulated in cancers of the prostate
US20040170982A1 (en) * 2003-02-14 2004-09-02 Morris David W. Novel therapeutic targets in cancer
WO2008026008A1 (en) * 2006-08-29 2008-03-06 Oxford Genome Sciences (Uk) Ltd Protein
US8535677B2 (en) 2006-06-06 2013-09-17 Oxford Biotherapeutics, Ltd. Antibody drug conjugate treatment of colorectal cancer
BRPI0912462B1 (en) 2008-08-05 2022-03-22 Toray Industries, Inc Use of an immunity-inducing agent, use of a polypeptide, and use of a recombinant vector
RU2498819C2 (en) 2008-08-05 2013-11-20 Торэй Индастриз, Инк. Pharmaceutical composition for treating and preventing malignant growths
DK2325648T3 (en) * 2008-08-05 2014-07-28 Toray Industries METHOD OF DETECTING CANCER
CN106188295A (en) 2009-04-20 2016-12-07 牛津生物疗法有限公司 It is specific to the antibody of cadherins 17
PT2532680E (en) 2010-02-04 2015-09-14 Toray Industries Medicinal composition for treating and/or preventing cancer
ES2691738T3 (en) 2010-02-04 2018-11-28 Toray Industries, Inc. Pharmaceutical agent for the treatment and / or prevention of cancer
AU2011211682B2 (en) * 2010-02-04 2015-08-13 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer
JP5742714B2 (en) * 2010-02-04 2015-07-01 東レ株式会社 Pharmaceutical composition for treatment and / or prevention of cancer
PL2532743T3 (en) 2010-02-04 2015-09-30 Toray Industries Pharmaceutical composition for treatment and/or prevention of cancer
MX342291B (en) * 2010-02-04 2016-09-23 Toray Industries Pharmaceutical composition for treatment and/or prevention of cancer.
AU2012290949B2 (en) 2011-08-04 2017-03-02 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of pancreatic cancer
PT2740795T (en) 2011-08-04 2017-01-09 Toray Industries Cancer treatment and/or prevention drug composition
US9180188B2 (en) 2011-08-04 2015-11-10 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prophylaxis of cancer
HUE039219T2 (en) 2011-08-04 2018-12-28 Toray Industries Pharmaceutical composition for treatment and/or prophylaxis of cancer
AU2012290955B2 (en) 2011-08-04 2017-04-27 Toray Industries, Inc. Drug composition for cancer treatment and/or prevention
AU2012290957B2 (en) 2011-08-04 2017-04-20 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prophylaxis of cancer
PT2741085T (en) 2011-08-04 2017-06-30 Toray Industries Method for detecting pancreatic cancer
KR102005786B1 (en) 2012-02-21 2019-07-31 도레이 카부시키가이샤 Medicinal composition for treating and/or preventing cancer
EP2818481B1 (en) 2012-02-21 2019-08-07 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer
JP6187255B2 (en) 2012-02-21 2017-08-30 東レ株式会社 Pharmaceutical composition for treatment and / or prevention of cancer
CA2865020C (en) 2012-02-21 2021-01-26 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer
PT2832366T (en) 2012-03-30 2018-01-25 Toray Industries Pharmaceutical composition for treatment and/or prevention of gallbladder cancer
BR112014023937A2 (en) 2012-03-30 2018-04-17 Toray Industries pharmaceutical composition, pharmaceutical combination and treatment method
CN104471403B (en) 2012-07-19 2017-03-01 东丽株式会社 The detection method of cancer
EP2876447B1 (en) 2012-07-19 2019-11-20 Toray Industries, Inc. Method for detecting cancer
MX360671B (en) 2013-08-09 2018-11-13 Toray Industries Pharmaceutical composition for treatment and/or prevention of cancer.
MX2018014602A (en) * 2016-05-27 2019-06-10 Etubics Corp Neoepitope vaccine compositions and methods of use thereof.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0478146A1 (en) * 1990-08-31 1992-04-01 The Wistar Institute DNA and polypeptide for tumor-associated antigen CO-029

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0478146A1 (en) * 1990-08-31 1992-04-01 The Wistar Institute DNA and polypeptide for tumor-associated antigen CO-029

Also Published As

Publication number Publication date
WO2002083070A2 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
WO2002083070A3 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
WO2001096388A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer
WO2001096390A3 (en) Compositions and methods for the therapy and diagnosis of colon cancer
WO2001000828A3 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2001040269A3 (en) Compositions and methods for therapy and diagnosis of breast cancer
WO2001075171A3 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
WO2001025272A3 (en) Compositions and methods for therapy and diagnosis of prostate cancer
WO2000037643A3 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
WO2000060077A3 (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
WO2000060076A3 (en) Compositions for the treatment and diagnosis of breast cancer and methods for their use
WO2000004149A3 (en) Compositions and methods for therapy and diagnosis of prostate cancer
WO2001034802A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
WO2001079286A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
WO2002074156A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer
WO2001073027A3 (en) Compositions and methods for therapy and diagnosis of colon cancer
WO2002092001A3 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2002074237A8 (en) Compositions and methods for the therapy and diagnosis of kidney cancer
WO2001049716A3 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
WO2000052165A3 (en) Compositions and methods for breast cancer therapy and diagnosis
WO2003037267A3 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2001057207A3 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
WO2000078960A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
WO2001051513A3 (en) Ovarian tumor-associated sequences
WO2001070976A3 (en) Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer
WO2001073031A3 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP